Literature DB >> 24505095

Angiotensin converting enzyme insertion/deletion (I/D) (rs4646994) and Vegf polymorphism (+405G/C; rs2010963) in type II diabetic patients: Association with the risk of coronary artery disease.

Atousa Moradzadegan1, Asad Vaisi-Raygani2, Abdolrahim Nikzamir3, Zohreh Rahimi4.   

Abstract

HYPOTHESIS: Little is known about the concomitant presence of the angiotensin-converting enzyme (ACE) (rs4646994) D allele and vascular endothelial growth factor(VEGF) (+405G/C; rs2010963) G allele on the susceptibility of coronary artery disease (CAD). Here we examined the hypothesis that ACE-D and VEGF-G alleles act synergistically to increase the severity of CAD in patients with type II diabetes mellitus (T2DM).
MATERIALS AND METHODS: The VEGF (rs2010963) and ACE (rs4646994) genotypes were detected by polymerase chain reaction - restriction fragment length polymorphism (PCR-RFLP) and PCR, respectively in 510 T2DM patients undergoing their first coronary angiography. Diabetic patients were classified as T2DM patients with and without CAD (control).
RESULTS: The crude odds ratio (OR) for the presence of CAD in ID+DD and D allele carriers were 1.98 (p=0.01) and 1.55 (p=0.001), respectively. Also, adjusted ORs in the presence of normolipidemia and the absence of history of hypertension for the risk of CAD in the either ACE(rs4646994) D allele or VGEF(rs2010963)-G alleles were 2.08 (p=0.004) and 1.75 (p=0.024), respectively. In addition, the concomitant presence of the ACE-D and VEGF-G alleles increased the risk of CAD 2.25-fold (p=0.043).
CONCLUSION: Our results indicated that ACE(rs4646994)-D allele alone and in the presence of VEGF(rs2010963)-G allele can be an important independent risk factor for susceptibility of CAD in T2DM patients even after correcting for conventional risk factors in a population of Iran.
© The Author(s) 2014.

Entities:  

Keywords:  Angiotensin converting enzyme (rs4646994); coronary artery disease; diabetes mellitus; genetic polymorphism; vascular endothelial growth factor (rs2010963)

Mesh:

Substances:

Year:  2014        PMID: 24505095     DOI: 10.1177/1470320313497819

Source DB:  PubMed          Journal:  J Renin Angiotensin Aldosterone Syst        ISSN: 1470-3203            Impact factor:   1.636


  19 in total

1.  Polymorphism of VEGF gene in susceptibility to chronic immune-mediated inflammatory diseases: a meta-analysis.

Authors:  Ni Wei; Zijia Chen; Zhifeng Xue; Yuelan Zhu
Journal:  Rheumatol Int       Date:  2015-05-26       Impact factor: 2.631

Review 2.  The Angiotensin-converting Enzyme Insertion/Deletion Polymorphism as a Common Risk Factor for Major Pregnancy Complications.

Authors:  Christos Yapijakis; Iphigenia Gintoni; Maria Adamopoulou
Journal:  In Vivo       Date:  2021 Jan-Feb       Impact factor: 2.155

3.  The impact of vascular endothelial growth factor +405 C/G polymorphism on long-term outcome and severity of coronary artery disease.

Authors:  Samira Kalayi Nia; Shayan Ziaee; Mohammad Ali Boroumand; Maryam Sotudeh Anvari; Leyla Pourgholi; Arash Jalali
Journal:  J Clin Lab Anal       Date:  2016-10-05       Impact factor: 2.352

4.  Case-control association study of polymorphisms in the angiotensinogen and angiotensin-converting enzyme genes and coronary artery disease and systemic artery hypertension in African-Brazilians and Caucasian-Brazilians.

Authors:  Ricardo Bonfim-Silva; Larissa Oliveira Guimarães; Jandson Souza Santos; Jaqueline Fagundes Pereira; Ana Angélica Leal Barbosa; Domingos Lazaro Souza Rios
Journal:  J Genet       Date:  2016-03       Impact factor: 1.166

5.  Association between the polymorphisms of the vascular endothelial growth factor gene and metabolic syndrome.

Authors:  Young Ree Kim; Seung-Ho Hong
Journal:  Biomed Rep       Date:  2015-02-04

6.  Association of ACE I/D and PAI-1 4G/5G polymorphisms with susceptibility to type 2 diabetes mellitus.

Authors:  Somaye Miri; Mohammad Hasan Sheikhha; Seyed Alireza Dastgheib; Seyed Amir Shaker; Hossein Neamatzadeh
Journal:  J Diabetes Metab Disord       Date:  2021-07-03

7.  Association between VEGF polymorphisms (936c/t, -460t/c and -634g/c) with haplotypes and coronary heart disease susceptibility.

Authors:  Xia Han; Lili Liu; Jiamin Niu; Jun Yang; Zengtang Zhang; Zhiqiang Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

8.  Association Between M235T-AGT and I/D-ACE Polymorphisms and Carotid Atheromatosis in Hypertensive Patients: A Cross-Sectional Study.

Authors:  Oana Mocan; Elena Buzdugan; Angela Cozma; Daniel Corneliu Leucuta; Dan Radulescu; Lucia Maria Procopciuc
Journal:  In Vivo       Date:  2020 Sep-Oct       Impact factor: 2.155

9.  Impact of renin-angiotensin-aldosterone system polymorphisms on myocardial perfusion: Correlations with myocardial single photon emission computed tomography-derived parameters.

Authors:  George Angelidis; Maria Samara; Maria Papathanassiou; Maria Satra; Varvara Valotassiou; Ioannis Tsougos; Dimitrios Psimadas; Chara Tzavara; Sotiria Alexiou; John Koutsikos; Nikolaos Demakopoulos; Gregory Giamouzis; Filippos Triposkiadis; John Skoularigis; Panagoula Kollia; Panagiotis Georgoulias
Journal:  J Nucl Cardiol       Date:  2018-01-17       Impact factor: 5.952

10.  Interactions of smoking with rs833061 polymorphism on the risk of non-alcoholic fat liver disease in Hubei Han population: a preliminary case-control study.

Authors:  Pengbo Wu; Yonglong Hua; Shiyun Tan; Ming Li; Shu Yongxiang; Guo Fang
Journal:  Iran J Basic Med Sci       Date:  2015-11       Impact factor: 2.699

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.